Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia

Séverine Landais1, Sébastien Landry, Philippe Legault

  • 1Laboratoire de Biologie Moléculaire, Département des Sciences Biologiques, Université du Québec à Montréal, Montreal, Quebec, Canada.

Cancer Research
|June 19, 2007
PubMed

Insights

Novel noncoding RNA (ncRNA) overexpression drives microRNA (miRNA) accumulation in T-cell leukemia. This ncRNA acts as a precursor to oncogenic miRNAs, potentially linking new genes to leukemia development.

Area of Science:

  • * Molecular Biology
  • * Oncology
  • * Genetics

Background:

  • * The Kis2 retrovirus integration site on mouse chromosome X is associated with radiation leukemia virus-induced T-cell leukemias.
  • * Tumors at the Kis2 locus exhibit overexpression of a novel noncoding RNA (ncRNA) lacking a polyA tail and possessing complex splicing.
  • * A microRNA (miRNA) cluster, miR-106-363, was identified downstream of the Kis2 ncRNAs.

Purpose of the Study:

  • * To investigate the relationship between Kis2 ncRNAs and the miR-106-363 cluster.
  • * To determine the oncogenic potential of miRNAs derived from Kis2 ncRNAs in T-cell leukemia.
  • * To identify target genes of the implicated miRNA cluster and establish their link to T-cell leukemia.

Main Methods:

  • * Analysis of ncRNA and miRNA expression in mouse T-cell leukemia models.
  • * Functional assays, including anchorage independence assays, to assess miRNA oncogenic potential.
  • * Confirmation of pri-miR-106-363 overexpression in human T-cell leukemia samples.
  • * Identification of miRNA target genes using bioinformatics and experimental validation.

Main Results:

  • * Kis2 ncRNAs function as the primary miRNA (pri-miRNA) for the miR-106-363 cluster.
  • * Overexpression of Kis2 ncRNA in mouse tumors leads to increased levels of specific miRNAs (miR-106a, miR-19b-2, miR-92-2, miR-20b).
  • * These miRNAs demonstrate oncogenic potential in vitro.
  • * Pri-miR-106-363 is overexpressed in 46% of human T-cell leukemias, correlating with elevated miR-92 and miR-19 levels.
  • * Myosin regulatory light chain-interacting protein, retinoblastoma-binding protein 1-like, and potentially homeodomain-interacting protein kinase 3 were identified as target genes.

Conclusions:

  • * Kis2 ncRNA is a critical precursor for oncogenic miRNAs involved in T-cell leukemia development.
  • * The overexpression of this ncRNA and subsequent miRNA accumulation contributes to leukemogenesis.
  • * This study establishes a novel link between the identified miRNA cluster and its target genes in the context of T-cell leukemia.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...